Barry Richard
Sarepta Therapeutics, Inc. · Director
Barry Richard is listed in filings as Director at Sarepta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Sarepta Therapeutics, Inc. (SRPT) and Cassava Sciences, Inc. (SAVA). The current snapshot covers public activity from Oct 1, 2024 to Jun 5, 2026. Reported amounts are shown as $414.0K to $16.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $202k73.4k shares | BuyNov 19, 2025 | $2.75 | $1.32 | |
| $16k7.2k shares | BuySep 22, 2025 | $2.28 | $1.32 | |
| $900400 shares | BuySep 19, 2025 | $2.25 | $1.32 | |
| $107k46.9k shares | BuySep 19, 2025 | $2.29 | $1.32 | |
| $415k185.2k shares | BuySep 18, 2025 | $2.24 | $1.32 | |
| $12k5.4k shares | BuySep 18, 2025 | $2.13 | $1.32 |